CARPENTER ROBERT J - 03 Aug 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
By: /s/ Michael D. Bookman, Attorney-in-Fact for Robert J. Carpenter
Issuer symbol
IMRX
Transactions as of
03 Aug 2021
Net transactions value
+$4,875,000
Form type
4
Filing time
04 Aug 2021, 06:05:32 UTC
Previous filing
29 Jul 2021
Next filing
23 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Conversion of derivative security +217,173 +36% 823,839 03 Aug 2021 Direct F1
transaction IMRX Class A Common Stock Purchase $4,875,000 +325,000 +39% $15.00 1,148,839 03 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Series A Preferred Stock Conversion of derivative security -94,585 -100% 0 03 Aug 2021 Class A Common Stock 94,585 Direct F1
transaction IMRX Series B Preferred Stock Conversion of derivative security -122,588 -100% 0 03 Aug 2021 Class A Common Stock 122,588 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.